Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Curr Pathobiol Rep. 2014 Jul 15;2(3):109–115. doi: 10.1007/s40139-014-0049-8

Figure 1.

Figure 1

MiR-122 increases in expression with steatosis which leads to Fibrosis, while being detected in the patient's serum. MiR-24 increases with hapatic exposure to Fatty acids, resulting in increased Insig1 expression which may increase steatosis. Steatosis may also increase miR-34a expression which then decreases SIRT1, leading to increased fibrosis.